Kazuya Kabayama Selected Research

G(M3) Ganglioside

1/2020	Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity.
1/2012	[Modulation of growth factor receptors in membrane microdomains].
6/2009	Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti.
10/2007	GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
8/2007	Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance.
7/2006	Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
1/2005	TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3.
2/2002	Ganglioside GM3 participates in the pathological conditions of insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuya Kabayama Research Topics

Disease

8	Neoplasms (Cancer) 07/2021 - 07/2006
7	Insulin Resistance 01/2018 - 02/2002
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2005
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Obesity 01/2020 - 01/2020
2	Lymphoma (Lymphomas) 01/2020 - 07/2006
2	Lung Neoplasms (Lung Cancer) 10/2007 - 07/2006
2	Lewis Lung Carcinoma 07/2006 - 03/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021
1	Glioma (Gliomas) 07/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Diabetes Mellitus 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Hypercholesterolemia 11/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Muscular Atrophy (Muscle Atrophy) 01/2015
1	Colonic Neoplasms (Colon Cancer) 10/2013
1	Colorectal Neoplasms (Colorectal Cancer) 10/2013
1	Cysts 04/2013
1	Deafness (Deaf Mutism) 06/2009
1	Carcinoma (Carcinomatosis) 10/2007
1	Adenocarcinoma 10/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2007
1	B-Cell Leukemia (Leukemia, B Cell) 07/2006

Drug/Important Bio-Agent (IBA)

8	G(M3) GangliosideIBA 01/2020 - 02/2002
6	GangliosidesIBA 11/2018 - 03/2003
5	Insulin ReceptorIBA 01/2018 - 02/2002
4	haematoside synthetaseIBA 10/2007 - 02/2002
3	AntigensIBA 01/2020 - 10/2013
3	Insulin (Novolin)FDA Link 08/2007 - 02/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2007 - 02/2002
2	Radioisotopes (Radionuclides)IBA 07/2021 - 03/2021
2	VaccinesIBA 01/2020 - 01/2018
2	EpitopesIBA 01/2018 - 10/2013
2	GlycosphingolipidsIBA 09/2015 - 04/2013
2	LipidsIBA 04/2013 - 01/2005
2	Messenger RNA (mRNA)IBA 10/2007 - 02/2002
1	monomethoxypolyethylene glycol (MPEG)IBA 07/2021
1	Ether (Diethyl Ether)IBA 07/2021
1	Sulfhydryl Compounds (Thiols)IBA 07/2021
1	Ethylene Glycol (Monoethylene Glycol)IBA 07/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 03/2021
1	Tyrosine (L-Tyrosine)FDA Link 03/2021
1	LipopolysaccharidesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	phosphatidylcholine-ceramide phosphocholine transferaseIBA 01/2020
1	Lipid AIBA 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	Cell Adhesion MoleculesIBA 01/2020
1	CeramidesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Polysaccharides (Glycans)IBA 12/2019
1	FucoseIBA 12/2019
1	AntibodiesIBA 01/2019
1	CholesterolIBA 11/2018
1	Apolipoproteins E (ApoE)IBA 11/2018
1	Dietary CholesterolIBA 11/2018
1	CarbohydratesIBA 01/2018
1	LeptinIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	AntioxidantsIBA 01/2015
1	Biological ProductsIBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 10/2013
1	Tn antigenIBA 10/2013
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2013
1	Monoclonal AntibodiesIBA 10/2013
1	Carrier Proteins (Binding Protein)IBA 10/2013
1	AcidsIBA 04/2013
1	RV 538 (PDMP)IBA 01/2012
1	GlycolipidsIBA 01/2012
1	MucinsIBA 10/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2007
1	Pharmaceutical PreparationsIBA 10/2007
1	Biomarkers (Surrogate Marker)IBA 10/2007
1	Tyrosine Kinase InhibitorsIBA 10/2007
1	Gefitinib (Iressa)FDA Link 10/2007
1	RTKI cpdIBA 10/2007
1	ErbB Receptors (EGF Receptor)IBA 10/2007
1	Caveolin 1IBA 08/2007
1	Complementary DNA (cDNA)IBA 07/2006
1	Etoposide (VP 16)FDA LinkGeneric 07/2006
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2006
1	Apoptosis Regulatory ProteinsIBA 07/2006
1	galactosylceramide sulfotransferaseIBA 03/2003
1	CDw17 antigen (lactosylceramide)IBA 03/2003
1	Insulin Receptor Substrate ProteinsIBA 02/2002
1	Glucose (Dextrose)FDA LinkGeneric 02/2002

Therapy/Procedure

2	Therapeutics 03/2021 - 11/2018
1	Denervation 01/2015
1	Lasers (Laser) 04/2013